Close Menu

Ebola

The Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation awarded the grant to Cepheid to develop the test.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals may not be able to meet its year-end goal of providing US regulators with the data required to lift a hold on a Phase I trial of its investigational Ebola therapy TKM-Ebola, company officials disclosed last week.

NEW YORK (GenomeWeb) – Host genetics appear to play a role in response to Ebola virus infection, researchers reported in a paper appearing online in Science today.

NEW YORK (GenomeWeb) — With a new technique to embed and freeze-dry genetic networks in paper, researchers from the Wyss Institute at Harvard University have taken the first steps toward moving a range of molecular diagnostics that currently rely on more complex technologies into a just-add-water

NEW YORK (GenomeWeb) – BioFire Defense, a BioMérieux company, has been granted Emergency Use Authorization by the US Food and Drug Administration for BioThreat-E, a commercially available Ebola molecular diagnostic test for use in CLIA moderate- and high-complexity laboratories.

NEW YORK (GenomeWeb) — BioMérieux yesterday reported approximately 4 percent organic revenue growth for the first nine months of 2014, driven by organic growth in all of its clinical application areas but particularly in molecular biology and immunoassays.

NEW YORK (GenomeWeb) – Using fever to screen for Ebola casts a wide net, while standard RT-PCR requires many hours and expert technicians.

NEW YORK (GenomeWeb) — Cepheid said last week that its third quarter revenues grew 15 percent year over year driven primarily by stronger than expected commercial clinical revenue resulting from new Xpert assays and customer types.

NEW YORK (GenomeWeb) — Tekmira Pharmaceuticals this week announced that it has started limited manufacturing of a new version of its siRNA Ebola treatment TKM-Ebola to specifically target the Guinea variant of the disease that is responsible for the current outbreak in Africa.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.